CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
GlobeNewswire
BERKELEY HEIGHTS, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on..
BERKELEY HEIGHTS, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on..
19 April 2024
*Biodexa Pharmaceuticals PLC*
(“Biodexa” or the “Company” or, together with its subsidiaries,..
- Intranasal foralumab attenuated microglial activation in patients with non-active secondary progressive multiple sclerosis and..